Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Outset MedicalOM -6.09%64 EV-to-EBITDA is -0.62 as of Aug. 07, 2026. GuruFocus rates OM with a GF Score™ of 64/100 and a GF Value™ of $4.18 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 512 Medical Devices & Instruments companies, Outset Medical ranks worse than 195312.3% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Outset Medical's enterprise value is $35.1 Mil.
Outset Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $-56.3 Mil. Therefore, Outset Medical's EV-to-EBITDA for today is -0.62.
The historical rank and industry rank for Outset Medical's EV-to-EBITDA or its related term are showing as below:
OM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -29.6 Med: -3.05 Max: 0.25
Current: -0.62
During the past 8 years, the highest EV-to-EBITDA of Outset Medical was 0.25. The lowest was -29.60. And the median was -3.05.
OM's EV-to-EBITDA is ranked worse than 100% of 512
companies
in the Medical Devices & Instruments industry
Industry Median: 14.645
vs OM: -0.62
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Outset Medical's PE Ratio (TTM) for today is calculated as:
Outset Medical's share price for today is $4.865.
Outset Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.160.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Outset Medical's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Outset Medical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Outset Medical EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Outset Medical's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Outset Medical's EV-to-EBITDA falls into.
Outset Medical's current Enterprise Value is $35.1 Mil.
Outset Medical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-56.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Outset Medical (OM) has a EV-to-EBITDA of -0.62 as of Aug. 07, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Outset Medical. According to the industry distribution chart, Outset Medical ranks #999999 out of 512 companies in the Medical Devices & Instruments industry.
Is Outset Medical's EV-to-EBITDA too high?
Outset Medical's current EV-to-EBITDA is -0.62. Based on the distribution chart, Outset Medical ranks #999999 out of 512 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Outset Medical has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Outset Medical's EV-to-EBITDA compare to SERA and LNSR?
According to the Medical Devices & Instruments industry distribution chart, Outset Medical ranks #999999 out of 512 companies for EV-to-EBITDA. This places Outset Medical in the lower half of its industry. The industry median EV-to-EBITDA is 14.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.65, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Outset Medical. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Outset Medical's current EV-to-EBITDA is -0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Outset Medical stock overvalued right now?
Based on GuruFocus' analysis, Outset Medical (OM) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.18, compared to a current price of $4.87 — trading 16.4% above its estimated fair value. The current EV-to-EBITDA is -0.62. Outset Medical's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Outset Medical (OM), the current EV-to-EBITDA is -0.62 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Outset Medical (OM) Overvalued in 2026?
Based on GuruFocus' analysis, Outset Medical stock appears to be overvalued.
The current stock price of $4.87 is trading 16.4% above its estimated GF Value™ of $4.18.
GuruFocus considers Outset Medical to be Modestly Overvalued.
Key valuation signals for OM:
EV-to-EBITDA: -0.62
GF Value™: $4.18 vs. price of $4.87 (16.4% above fair value)
No single metric tells the full story. See the OM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
64GF Score
Get the complete analysis for OM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OM has been successfully added to your 
